Order Article Reprints

Abo Elmaaty A, Eldehna WM, Khattab M, Kutkat O, Alnajjar R, El-Taweel AN, Al-Rashood ST, Abourehab MAS, Binjubair FA, Saleh MA, et al. Anticoagulants as Potential SARS-CoV-2 M^pro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies. International Journal of Molecular Sciences. 2022; 23(20):12235. https://doi.org/10.3390/ijms232012235

Abo Elmaaty, Ayman, Wagdy M. Eldehna, Muhammad Khattab, Omnia Kutkat, Radwan Alnajjar, Ahmed N. El-Taweel, Sara T. Al-Rashood, Mohammed A. S. Abourehab, Faizah A. Binjubair, Mohamed A. Saleh, and et al. 2022. "Anticoagulants as Potential SARS-CoV-2 M^pro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies" International Journal of Molecular Sciences 23, no. 20: 12235. https://doi.org/10.3390/ijms232012235

Abo Elmaaty, A., Eldehna, W. M., Khattab, M., Kutkat, O., Alnajjar, R., El-Taweel, A. N., Al-Rashood, S. T., Abourehab, M. A. S., Binjubair, F. A., Saleh, M. A., Belal, A., & Al-Karmalawy, A. A. (2022). Anticoagulants as Potential SARS-CoV-2 M^pro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies. International Journal of Molecular Sciences, 23(20), 12235. https://doi.org/10.3390/ijms232012235